Dongwha Pharm.Co.Ltd (000020) — Cash Flow Quality Index
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow Quality Index of 0.07x as of March 2026. Operating cash flow of ₩697.02 Million is below net income of ₩10.02 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 000020 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dongwha Pharm.Co.Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Dongwha Pharm.Co.Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000020 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year earnings quality comparison for Dongwha Pharm.Co.Ltd. For live market cap and the full company financial profile, see 000020 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.81x | ₩15.70 Billion | ₩8.69 Billion | ▲ +351.2% |
| 2024 | -0.72x | ₩-4.00 Billion | ₩5.56 Billion | ▼ -167.7% |
| 2023 | 1.06x | ₩29.17 Billion | ₩27.44 Billion | ▼ -25.8% |
| 2022 | 1.43x | ₩29.22 Billion | ₩20.38 Billion | ▼ -28.9% |
| 2021 | 2.02x | ₩36.03 Billion | ₩17.87 Billion | ▲ +10.1% |
| 2020 | 1.83x | ₩52.23 Billion | ₩28.51 Billion | ▲ +29.7% |
| 2019 | 1.41x | ₩13.28 Billion | ₩9.40 Billion | ▲ +426.3% |
| 2018 | -0.43x | ₩-4.36 Billion | ₩10.07 Billion | ▼ -23.2% |
| 2017 | -0.35x | ₩-16.52 Billion | ₩47.01 Billion | ▼ -136.2% |
| 2016 | 0.97x | ₩25.48 Billion | ₩26.25 Billion | ▼ -72.6% |
| 2015 | 3.54x | ₩19.83 Billion | ₩5.61 Billion | ▲ +29.2% |
| 2014 | 2.74x | ₩13.51 Billion | ₩4.94 Billion | ▼ -66.2% |
| 2013 | 8.11x | ₩8.21 Billion | ₩1.01 Billion | ▼ -57.9% |
| 2012 | 19.24x | ₩25.23 Billion | ₩1.31 Billion | ▲ +635.5% |
| 2011 | 2.62x | ₩46.24 Billion | ₩17.68 Billion | — |